Calcium chloride Solution for Intravenous Injection
Recall D-0061-2024, part of FDA recall event 93154. See Pine Pharmaceuticals's company page.
Pine Pharmaceuticals, LLC started this Class II drug recall on Oct 2, 2023 (voluntary: firm initiated); FDA lists it as terminated, terminated May 15, 2024.
- Classification: Class II
- Started: Oct 2, 2023
- Status: Terminated
Lack of Assurance of Sterility
- Product
- Calcium chloride Solution for Intravenous Injection, 20 mg/mL, 500 mL bags, Rx only, Compounded by Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.
- Quantity
- 130
- Lots and codes
- Lot #: 70101, Exp. Date 1/17/2024
- Distribution
- Nationwide within the United States
- Recalling firm
- Pine Pharmaceuticals, LLC, Tonawanda, NY, United States
- How the firm notified
- Letter
- FDA classified
- Oct 19, 2023
FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA drug enforcement reports